NCT05395260View on ClinicalTrials.gov

FL- 101 Study in Non-Metastatic MIBC

EARLY_PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 22, 2022

Primary Completion Date

November 28, 2022

Study Completion Date

December 28, 2022

Conditions
Muscle Invasive Bladder Carcinoma
Interventions
DRUG

FL-101

FL-101 200mg IV

Sponsors

Lead Sponsor

Flame Biosciences
All Listed Sponsors
lead

Flame Biosciences

INDUSTRY